Highlights

  • EBR Systems completed its fully underwritten Institutional Placement and Institutional Entitlement Offer.
  • The institutional funding initiative raised approximately A$106.4 million.
  • Institutional Placement generated A$64.4 million from existing and new eligible investors.
  • Institutional Entitlement Offer raised A$42.0 million in gross proceeds.
  • Retail Entitlement Offer is expected to raise a further approximately A$43.6 million.

EBR Systems Inc. (ASX:EBR) has announced the successful completion of the institutional components of its previously announced Capital raising initiative, securing significant funding to support the company’s future plans.

The medical technology company confirmed that both its fully underwritten Institutional Placement and Institutional Entitlement Offer were completed successfully, with strong participation from existing investors as well as new institutional participants.

Shares of EBR Systems were trading at AUD 0.38 during the afternoon session on 5 June 2026, down 18.09% for the day. The stock also remains down 65.32% over the past year.

Based in Silicon Valley, EBR Systems develops wireless cardiac pacing technology designed to improve treatment Options for patients suffering from cardiac rhythm disorders and heart failure. The company's proprietary Wireless Stimulation Endocardially (WiSE) technology is designed to eliminate the need for conventional pacing leads, which have historically been associated with complications and reliability issues in cardiac rhythm management.

Institutional Funding Initiative Raises More Than A$100 Million

The latest announcement follows the capital raising initiative unveiled by EBR on 4 June 2026.

According to the company, the Institutional Placement and Institutional Entitlement Offer collectively raised approximately A$106.4 million at an issue price of A$0.38 per new CHESS Depositary Interest (CDI).

The funding package comprises three primary components.

The first Tranche of the Institutional Placement generated approximately A$29.4 million and does not require Shareholder approval.

A second tranche of the placement is expected to contribute a further A$35.0 million, subject to approval from shareholders at a future extraordinary general meeting.

Meanwhile, the Institutional Entitlement Offer contributed gross proceeds of approximately A$42.0 million.

Management indicated that the outcome reflected support from both existing securityholders and new institutional investors.

Institutional Placement Receives Broad Investor Support

A significant portion of the capital raising came through the Institutional Placement.

The company reported that eligible institutional investors participated across both placement tranches, resulting in total commitments of approximately A$64.4 million.

Of this amount, approximately A$29.4 million will be issued under the first tranche, while A$35.0 million remains subject to shareholder approval under the second tranche.

The participation of institutional investors was viewed by management as an important component of the overall funding strategy.

The company also disclosed that certain existing shareholders advised by Brandon Capital committed A$35.0 million through the second placement tranche.

This support represented a substantial portion of the placement funding and demonstrated continued backing from existing institutional Stakeholders.

Entitlement Offer Generates Additional Capital

Alongside the placement, EBR completed the institutional component of its accelerated non-renounceable entitlement offer.

The Institutional Entitlement Offer raised approximately A$42.0 million in gross proceeds.

Eligible institutional securityholders took up approximately A$8.4 million worth of entitlements directly.

The remaining A$33.6 million of institutional entitlements, including those attributable to foreign ineligible shareholders, were allocated to eligible institutional and sophisticated investors through a bookbuild process.

This approach enabled the company to secure the targeted funding while maintaining the structure of the entitlement offer.

Management noted that the institutional component forms one part of a broader entitlement offer programme that also includes a retail component.

Retail Offer to Open Next Week

Following completion of the institutional component, EBR is preparing to launch the retail phase of the entitlement offer.

The Retail Entitlement Offer is expected to open on 11 June 2026 and close on 22 June 2026.

The company indicated that approximately A$43.6 million could be raised through the retail offer.

Importantly, the retail component is fully underwritten.

Eligible retail investors will be able to participate on the basis of one new CDI for every two existing securities held as of the Record Date.

Participation is limited to eligible retail securityholders with registered addresses in Australia or New Zealand who meet the offer requirements outlined by the company.

Further details are expected to be provided through the Retail Entitlement Offer Booklet, scheduled for release on 11 June.

Funding Backed by Existing Strategic Investors

One notable aspect of the capital raising was the participation of funds advised by Brandon Capital.

According to the company, these investors subscribed for A$35.0 million under the second placement tranche.

In addition, they committed approximately A$11.65 million as sub-underwriters of the Retail Entitlement Offer.

This support provides additional confidence in the completion of the broader fundraising initiative and contributes to the Underwriting arrangements supporting the retail component.

The involvement of existing investors can also help provide continuity as the company progresses its strategic objectives.

Trading halt Expected to End

Following successful completion of the institutional components of the capital raising, EBR stated that it expects the ASX trading halt to be lifted.

The company indicated that normal trading was expected to resume on 5 June 2026 on an ex-entitlement basis.

Settlement of securities issued under the Institutional Entitlement Offer and the first placement tranche is expected to occur on 11 June 2026.

Those securities are anticipated to be allotted and commence trading on 12 June 2026.

The second placement tranche, which remains subject to shareholder approval, is expected to settle during August 2026 if approved at the company's extraordinary general meeting.

Company Continues to Advance Wireless Cardiac Pacing Technology

EBR Systems remains focused on commercialising its wireless pacing platform.

The company’s WiSE technology is designed to provide endocardial stimulation of the heart's left ventricle without the use of conventional pacing wires.

According to EBR, the system is currently the only wireless endocardial pacing technology in clinical use for left ventricular stimulation.

The technology is intended to address patients requiring Cardiac Resynchronisation Therapy (CRT), a treatment commonly used in heart failure management.

Management believes future applications could extend beyond CRT into additional cardiac pacing and non-cardiac indications.

As a medical technology company operating in a highly specialised healthcare segment, access to capital remains an important element in supporting product development, commercial activities, regulatory initiatives and broader growth objectives.

Capital Raising Structure Reflects Multi-Stage Approach

The funding initiative has been structured in multiple stages to accommodate both institutional and retail participation.

The initial institutional phase has now been completed, while the retail offer remains scheduled for later this month.

The second placement tranche remains contingent upon shareholder approval.

If all components proceed as planned, the company will have completed one of its more substantial funding initiatives in recent years.

Investors will likely monitor participation levels in the retail component, shareholder approval outcomes and future updates regarding the company's commercial and operational priorities.

What This Means for Investors

EBR Systems has successfully completed the institutional components of its capital raising initiative, securing approximately A$106.4 million through the Institutional Placement and Institutional Entitlement Offer.

The company is now progressing toward the retail component, which could raise an additional A$43.6 million. The funding initiative has received support from both new and existing institutional investors, including significant commitments from Brandon Capital-advised funds.

Investors will likely focus on the outcome of the Retail Entitlement Offer, approval of the second placement tranche and how the additional capital supports EBR’s long-term commercialisation strategy for its wireless cardiac pacing technology.